ePrivacy and GPDR Cookie Consent by Cookie Consent
← back

The advancing utility of genomic testing in routine oncology practice

Friday February 8th 2019 | 10:00 AM


What you'll discover

Modern molecular technologies yield large amounts of genomic data from tumour and plasma DNA. Questions remain, however, as to how this information can be used in routine clinical practice


About the speaker(s)

picture of Dr. Philip Beer

Dr. Philip Beer

Physician scientist and precision oncology specialist (United Kingdom)

Dr Philip Beer is a physician scientist and precision oncology specialist who operates across the commercial, academic and healthcare sectors. Current projects include clinical implementation of cancer genomics, biomarker discovery and early phase clinical trials, underpinned by a portfolio of relevant academic research.